Oral anticoagulant therapy and risk of admission to long-term care in patients with atrial fibrillation : a nationwide cohort study

K Teppo; KEJ Airaksinen; O Halminen; M Linna; J Jaakkola; J Haukka; J Putaala; P Mustonen; VL Langen; J Kinnunen; J Hartikainen; M Lehto

doi:10.1093/eurheartj/ehad655.281

Oral anticoagulant therapy and risk of admission to long-term care in patients with atrial fibrillation : a nationwide cohort study

K Teppo
, KEJ Airaksinen
, O Halminen
, M Linna
, J Jaakkola
, J Haukka
, J Putaala
, P Mustonen
, VL Langen
, J Kinnunen
, J Hartikainen
, M Lehto

Department of Industrial Engineering and Management

Research output: Contribution to journal › Meeting Abstract › Scientific › peer-review

Original language	English
Article number	ehad655.281
Number of pages	2
Journal	European Heart Journal
Volume	44
Issue number	Suppl. 2
DOIs	https://doi.org/10.1093/eurheartj/ehad655.281
Publication status	Published - Nov 2023
MoE publication type	Not Eligible
Event	European Society of Cardiology Congress - Amsterdam, Netherlands Duration: 25 Aug 2023 → 28 Aug 2023

Access to Document

10.1093/eurheartj/ehad655.281

Cite this

Teppo, K., Airaksinen, KEJ., Halminen, O., Linna, M., Jaakkola, J., Haukka, J., Putaala, J., Mustonen, P., Langen, VL., Kinnunen, J., Hartikainen, J., & Lehto, M. (2023). Oral anticoagulant therapy and risk of admission to long-term care in patients with atrial fibrillation : a nationwide cohort study. European Heart Journal, 44(Suppl. 2), Article ehad655.281. https://doi.org/10.1093/eurheartj/ehad655.281

@article{807c0745c2444590a8f3b9f1967578b0,

title = "Oral anticoagulant therapy and risk of admission to long-term care in patients with atrial fibrillation : a nationwide cohort study",

author = "K Teppo and KEJ Airaksinen and O Halminen and M Linna and J Jaakkola and J Haukka and J Putaala and P Mustonen and VL Langen and J Kinnunen and J Hartikainen and M Lehto",

year = "2023",

month = nov,

doi = "10.1093/eurheartj/ehad655.281",

language = "English",

volume = "44",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "Suppl. 2",

note = "European Society of Cardiology Congress, ESC ; Conference date: 25-08-2023 Through 28-08-2023",

}

Teppo, K, Airaksinen, KEJ, Halminen, O, Linna, M, Jaakkola, J, Haukka, J, Putaala, J, Mustonen, P, Langen, VL, Kinnunen, J, Hartikainen, J & Lehto, M 2023, 'Oral anticoagulant therapy and risk of admission to long-term care in patients with atrial fibrillation : a nationwide cohort study', European Heart Journal, vol. 44, no. Suppl. 2, ehad655.281. https://doi.org/10.1093/eurheartj/ehad655.281

TY - JOUR

T1 - Oral anticoagulant therapy and risk of admission to long-term care in patients with atrial fibrillation : a nationwide cohort study

AU - Teppo, K

AU - Airaksinen, KEJ

AU - Halminen, O

AU - Linna, M

AU - Jaakkola, J

AU - Haukka, J

AU - Putaala, J

AU - Mustonen, P

AU - Langen, VL

AU - Kinnunen, J

AU - Hartikainen, J

AU - Lehto, M

PY - 2023/11

Y1 - 2023/11

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=aalto_pure&SrcAuth=WosAPI&KeyUT=WOS:001115619400282&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1093/eurheartj/ehad655.281

DO - 10.1093/eurheartj/ehad655.281

M3 - Meeting Abstract

SN - 0195-668X

VL - 44

JO - European Heart Journal

JF - European Heart Journal

IS - Suppl. 2

M1 - ehad655.281

T2 - European Society of Cardiology Congress

Y2 - 25 August 2023 through 28 August 2023

ER -

Oral anticoagulant therapy and risk of admission to long-term care in patients with atrial fibrillation : a nationwide cohort study

Access to Document

Other files and links

Cite this